Moreover, elevated levels of complement C3 were associated with increased risk of new cardiovascular events in women with severe CHD [19], and acted as a predictor of future MI in men without previous manifestation of atherosclerotic disease [20]. This evidence concerns the gene C3 and coronary artery disorder.